BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1690870)

  • 1. Analysis of mutant forms of the c-src gene product containing a phenylalanine substitution for tyrosine 416.
    Ferracini R; Brugge J
    Oncogene Res; 1990; 5(3):205-19. PubMed ID: 1690870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
    Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
    Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
    MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
    Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
    Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
    Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
    Yaciuk P; Cannella MT; Shalloway D
    Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific kinase activity and phosphorylation state of pp60c-src from neuroblastomas and fibroblasts.
    Yang XM; Walter G
    Oncogene; 1988 Sep; 3(3):237-44. PubMed ID: 2462704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts.
    Cooper JA; Runge K
    Oncogene Res; 1987; 1(4):297-310. PubMed ID: 2453017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From c-src to v-src, or the case of the missing C terminus.
    Sefton BM; Hunter T
    Cancer Surv; 1986; 5(2):159-72. PubMed ID: 2430701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants.
    Jove R; Hanafusa T; Hamaguchi M; Hanafusa H
    Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
    Jackson PK; Paskind M; Baltimore D
    Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of Ser-17 of pp60c-src: biological and biochemical characterization in chicken embryo fibroblasts.
    Hirota Y; Kato J; Takeya T
    Mol Cell Biol; 1988 Apr; 8(4):1826-30. PubMed ID: 2454397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between c-src tyrosine kinase activity and the control of glucose transporter gene expression.
    Matsouka PT; Flier JS
    Mol Endocrinol; 1989 Nov; 3(11):1845-51. PubMed ID: 2481817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular src gene product regulates junctional cell-to-cell communication.
    Azarnia R; Reddy S; Kmiecik TE; Shalloway D; Loewenstein WR
    Science; 1988 Jan; 239(4838):398-401. PubMed ID: 2447651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.